Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Dupilumab in AERD
NCT05031455Phase 2Completed
- Sponsor
- Scripps Clinic
- Start
- Mar 2024
- Primary completion
- Apr 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Scripps Clinic. Started Mar 2024; status: completed.
02
Drugs
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT05031455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05031455.